Table of Contents
Journal of the American Society of Nephrology
by
2w ago
No abstract available ..read more
Visit website
Cover Image
Journal of the American Society of Nephrology
by
2w ago
No abstract available ..read more
Visit website
The Challenge of Assessing Remission and Relapse in ANCA Kidney Disease
Journal of the American Society of Nephrology
by
2w ago
No abstract available ..read more
Visit website
Secular Trends in Incidence of Treated Kidney Failure in the United States
Journal of the American Society of Nephrology
by
2w ago
No abstract available ..read more
Visit website
Watering Collecting Duct Cysts: Are Aquaporin2+ Progenitors the Answer?
Journal of the American Society of Nephrology
by
2w ago
No abstract available ..read more
Visit website
Heterogeneity of Distal Convoluted Tubule Cells
Journal of the American Society of Nephrology
by
2w ago
No abstract available ..read more
Visit website
The Ip6k1 and Ip6k2 Kinases Are Critical for Normal Renal Tubular Function
Journal of the American Society of Nephrology
by
2w ago
Significance Statement Kidneys are gatekeepers of systemic inorganic phosphate balance because they control urinary phosphate excretion. In yeast and plants, inositol hexakisphosphate kinases (IP6Ks) are central to regulate phosphate metabolism, whereas their role in mammalian phosphate homeostasis is mostly unknown. We demonstrate in a renal cell line and in mice that Ip6k1 and Ip6k2 are critical for normal expression and function of the major renal Na+/Pi transporters NaPi-IIa and NaPi-IIc. Moreover, Ip6k1/2−/− mice also show symptoms of more generalized kidney dysfunction. Thus, our results ..read more
Visit website
Age- and Race-Specific Changes in ESKD Incidence over Four Decades
Journal of the American Society of Nephrology
by
2w ago
Significance Statement ESKD incidence has changed substantially in the past four decades, but differences by age and race have been unexplored. Using data from the United States Renal Data System, we found that ESKD incidence rose for Black and White teenagers, adults, and older adults for two decades beginning in 1980. Growth in incidence slowed for most groups by 1993, and by 2006, the annual percent change (APC) in ESKD incidence had declined for all groups, except White adults, for whom rates continued to rise. By 2019, ESKD incidence among Black and White adolescents nearly returned to 19 ..read more
Visit website
Pkd2 Deficiency in Embryonic Aqp2+ Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease
Journal of the American Society of Nephrology
by
2w ago
Significance Statement Autosomal dominant polycystic kidney disease (ADPKD) is a devastating disorder caused by mutations in polycystin 1 (PKD1) and polycystin 2 (PKD2). Currently, the mechanism for renal cyst formation remains unclear. Here, we provide convincing and conclusive data in mice demonstrating that Pkd2 deletion in embryonic Aqp2+ progenitor cells (AP), but not in neonate or adult Aqp2+ cells, is sufficient to cause severe polycystic kidney disease (PKD) with progressive loss of intercalated cells and complete elimination of α-intercalated cells, accurately recapitulating a newly i ..read more
Visit website
Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria
Journal of the American Society of Nephrology
by
2w ago
Significance Statement Proteinuria predicts accelerated decline in kidney function in CKD. The pathologic mechanisms are not well known, but aberrantly filtered proteins with enzymatic activity might be involved. The urokinase-type plasminogen activator (uPA)-plasminogen cascade activates complement and generates C3a and C5a in vitro/ex vivo in urine from healthy persons when exogenous, inactive, plasminogen, and complement factors are added. Amiloride inhibits uPA and attenuates complement activation in vitro and in vivo. In conditional podocin knockout (KO) mice with severe proteinuria, bloc ..read more
Visit website

Follow Journal of the American Society of Nephrology on FeedSpot

Continue with Google
Continue with Apple
OR